The Muscarinic Cholinergic System’s Role in Schizophrenia: Pathophysiology and Emerging Treatments

Sponsor: HMP Education: Global Learning Network

This on-demand activity discusses strategies for patient-centered communication, including shared decision-making and motivational interviewing, to facilitate treatment selection and acceptance.

Learning Objectives: After participating in this activity, learners should be better able to:

  • Assess barriers to optimal schizophrenia treatment, and outline strategies to overcome these barriers
  • Evaluate the pharmacology, mechanisms of action, safety/efficacy data, and administration considerations associated with novel antipsychotic formulations targeting the muscarinic cholinergic system
  • Describe how different MOAs can potentially be synergistic and when it may be beneficial to combine two MOAs to improve efficacy
  • Implement strategies for patient-centered communication, including shared decision-making and motivational interviewing, to facilitate treatment selection and acceptance.

For more information and to register click here

This is an open ended event

Cost:
no costs